Science AI Journal
Medicine · Research topic

Open research questions in Neurofibromatosis and Schwannoma Cases

112 unresolved questions extracted from the limitations and future-work sections of 433 Neurofibromatosis and Schwannoma Cases papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Complementing existing international recommendations, it offers practical guidance in areas where evidence remains limited.

    Management of plexiform neurofibromas in neurofibromatosis type 1: An Italian Delphi consensus · 2026 · DOI

  • Despite availability of international recommendations for tumor surveillance in NF1, several aspects of PN management remain incompletely defined in clinical practice.

    Management of plexiform neurofibromas in neurofibromatosis type 1: An Italian Delphi consensus · 2026 · DOI

  • Their 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) appearance has not been characterized in a patient series.

    FDG PET characteristics of intraneural perineurioma: patient series · 2026 · DOI

  • Future research should focus on larger cohort studies and the development of tailored strategies for managing specific gene mutations.

    Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC · 2025 · DOI

  • In addition to unraveling the mechanism of tumor formation, further investigation of adipocytes and collagen modifications in preneoplastic mammary glands will create a foundation for developing early detection strategies of breast cancer among NF1 patients.

    Nf1 deficiency modulates the stromal environment in the pretumorigenic rat mammary gland · 2024 · DOI

  • The mechanism by which NF1 mutations lead to breast cancer tumorigenesis is not well understood.

    Nf1 deficiency modulates the stromal environment in the pretumorigenic rat mammary gland · 2024 · DOI

  • Although it has been widely demonstrated that the TME is involved in the formation of neurofibromas, little is known about the effects of the TME on the subsequent progression of human pNF1.

    A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids · 2024 · DOI

  • The risk of radiation-induced tumors in patients with neurofibromatosis type 1. The limited effectiveness of current treatment options for low-grade gliomas in these patients. The need for careful consideration of the risks and benefits of radiotherapy in these patients.

    Radiotherapy for low grade gliomas in children with neurofibromatosis type 1: when there is no other choice. Case Report · 2026 · DOI

  • The use of radiotherapy in patients with neurofibromatosis type 1 is limited due to the risk of radiation-induced tumors. The sample size of this study is small, with only two cases reported.

    Radiotherapy for low grade gliomas in children with neurofibromatosis type 1: when there is no other choice. Case Report · 2026 · DOI

  • Solitary neurofibromas are rare in the oral cavity, particularly in the hard palate. There is a need for increased awareness and consideration of neurofibroma in the differential diagnosis of palatal swellings.

    Solitary neurofibroma of the hard palate: A rare case report · 2026 · DOI

  • The diagnostic uncertainty and substantial surgical challenges related to neural decompression, maximal safe resection, and spinal stabilization in giant spinal schwannomas. The lack of reliable discriminators between benign and malignant peripheral nerve sheath lesions.

    Case Report: Giant L1 dumbbell-shaped spinal schwannoma with osteolytic destruction and intense [18F]FDG uptake on PET/CT mimicking a malignant tumor · 2026 · DOI

  • In this setting, tracer avidity and bone erosion alone are insufficient to infer malignancy; instead, integrated interpretation of MRI/CT morphology, metabolic imaging for extent mapping and staging, and clinicoradiologic context is essential.

    Case Report: Giant L1 dumbbell-shaped spinal schwannoma with osteolytic destruction and intense [18F]FDG uptake on PET/CT mimicking a malignant tumor · 2026 · DOI

  • The use of AI in rare diseases is associated with challenges such as standardizing small patient groups. The necessity of interdisciplinary collaboration between experts in genetics, bioinformatics, laboratory medicine, and clinical medicine. The lack of detailed information about the AI4NEF platform, including its architecture, validation process, and clinical implementation.

    Artificial intelligence in neurofibromatosis type I: diagnostic and therapeutic opportunities · 2026 · DOI

  • The development of more advanced AI models to support therapeutic decision-making in NF1. The integration of AI with other technologies, such as genomic analysis, to improve diagnosis and treatment. The evaluation of the effectiveness of AI-based platforms, such as AI4NEF, in clinical settings.

    Artificial intelligence in neurofibromatosis type I: diagnostic and therapeutic opportunities · 2026 · DOI

  • Diagnostic challenges due to the rarity of isolated rectal neurofibroma. Management challenges due to the uncertain biological potential of these lesions. The need for further genomic and longitudinal investigations.

    Isolated rectal neurofibroma in the absence of neurofibromatosis: report and review of molecular implications · 2026 · DOI

  • The rarity of isolated colorectal neurofibromas limits the understanding of their natural history, molecular landscape, and malignant potential. Further genomic and longitudinal investigations are needed.

    Isolated rectal neurofibroma in the absence of neurofibromatosis: report and review of molecular implications · 2026 · DOI

  • The study identifies a gap in the understanding of the genetic and proteomic profiles of NF1 and NF2 tumors. The study aims to address this gap by investigating the common molecular links in the tumorigenesis of NF1 and NF2.

    Loss of EPB41L3: a common molecular link in the tumorigenesis of neurofibromatosis types 1 and 2 · 2026 · DOI

  • The occult nature of gastrointestinal involvement in NF-1. The lack of specific clinical symptoms often leads to diagnostic confusion with other gastrointestinal disorders.

    Mesenteric neurofibromatosis complicated by acute appendicitis: case report and review of the literature · 2026 · DOI

  • One challenge is the difficulty in distinguishing neurofibroma from schwannoma using MRI. Another challenge is the potential for malignant transformation in NF1 patients. A third challenge is the need for ongoing vigilance for interval morphological change in NF1 patients.

    Ultrasonography for Surgical Planning and Follow-Up in Neurofibromatosis Type 1 · 2026 · DOI

  • further study on the utility of ultrasonography for detecting peripheral nerve changes in NF1 patients over time, - investigation of the role of ultrasonography in the long-term management of NF1-associated peripheral nerve tumors

    Ultrasonography for Surgical Planning and Follow-Up in Neurofibromatosis Type 1 · 2026 · DOI

  • The surgical treatment of NF-1-related kyphoscoliosis tends to be challenging and complex, - There is a need for a systematic review of the literature on the surgical complications of kyphoscoliosis secondary to NF-1

    Surgical complications of kyphoscoliosis secondary to neurofibromatosis type 1: a systematic review · 2026 · DOI

  • Further studies are needed to validate the optimized DFV selection algorithm in larger cohorts. Research is needed to explore the application of the optimized algorithm in other types of scoliosis. Studies are needed to investigate the cost-effectiveness of the optimized algorithm.

    Distal fusion vertebra selection in neurofibromatosis type 1 scoliosis: integrating CT/MRI-detected atrophic changes reduces long-term mechanical complications · 2026 · DOI

  • The lack of a systematic approach to integrating CT/MRI-detected atrophic changes with AIS criteria in DFV selection for NF1 scoliosis. The limited understanding of the relationship between atrophic changes and postoperative complications in NF1 scoliosis.

    Distal fusion vertebra selection in neurofibromatosis type 1 scoliosis: integrating CT/MRI-detected atrophic changes reduces long-term mechanical complications · 2026 · DOI

  • Quantitative evidence addressing the likelihood that a child presenting exclusively with CALMs will later fulfill diagnostic criteria for NF1 is limited. The age-dependent expression and variable clinical penetrance of NF1 can delay clinical confirmation despite early cutaneous findings.

    Early quantitative progression of café-au-lait macules and diagnostic threshold fulfilment by 24 months in neurofibromatosis type 1 · 2026 · DOI

  • In summary, while CALMs alone are insufficient to establish NF1 in early infancy, our findings demonstrate a clear and progressive increase in lesion burden during the first two years of life in genetically confirmed cases.

    Early quantitative progression of café-au-lait macules and diagnostic threshold fulfilment by 24 months in neurofibromatosis type 1 · 2026 · DOI

Most-cited papers in Neurofibromatosis and Schwannoma Cases

Most recent work

Find a gap in your own Neurofibromatosis and Schwannoma Cases sub-topic

This page shows what the Neurofibromatosis and Schwannoma Cases literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,044 open questions
Substance Abuse Treatment and Outcomes
1,964 open questions
Smoking Behavior and Cessation
990 open questions
Dementia and Cognitive Impairment Research
974 open questions
Innovations in Medical Education
960 open questions
Physical Activity and Health
923 open questions
Attention Deficit Hyperactivity Disorder
839 open questions
Schizophrenia research and treatment
709 open questions
112 open questions have been extracted from the limitations and future-work passages of 433 Neurofibromatosis and Schwannoma Cases papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.